By Malcolm Stacey | Monday 15 May 2017
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Hello Share Squirters. As I get older, I become more fearful about my health. Apart from a minor problem with the old prostate, I am not yet troubled by illness. But I think disaster may be around the corner, especially if I do not watch my diet and take preventative steps to slow down wearing out. So it would only be fair to consider buying shares in a company which fulfils those needs.
Venture Life Group (VLG) is finding and developing products to keep us healthy, especially for the over-forties. (And for people like me in their extremely late twenties).
The share price has not been great thus far, but we are all getting older and many much more frail and rickety. So we can assume the market is strong and getting stronger. This is the message that Venture Life put across strongly at the big UK Investor Show in April.
The company makes the products and sells through distributers to retailers. For example, it does a skin care range which has done very well in China (it seems everyone wants to do business with that growing country these days).
The company is also into making capsules which lower cholesterol, tackling a big problem these days. And it has a range of memory and brain supplements which is on sales in Europe and Canada. Plus a toothpaste line which knocks out bad breath. Last year’s pre tax loss of £600,000 turned into an EBITDA profit of £800,000 this time round.
Companies which turn around as fast as that always deserve further research. As I’ve shown, its range of products is pretty diverse and so the chances of success are increased.
Now let’s venture into the Punter’s Return.
Never miss a story.
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Comments are turned off for this article.
Search ShareProphets |
Stock market news |
Recent Comments |